zolmitriptan- zolmitriptan tablet zolmitriptan orally disintegrating- zolmitriptan tablet, orally disintegrating
impax generics - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 2.5 mg - zolmitriptan tablets and zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. limitations of use zolmitriptan tablets and zolmitriptan orally disintegrating tablets are contraindicated in patients with: risk summary there are no adequate data on the developmental risk associated with the use of zolmitriptan in pregnant women. in reproductive toxicity studies in rats and rabbits, oral administration of zolmitriptan to pregnant animals resulted in embryolethality and fetal abnormalities (malformations and variations) at clinically relevant exposures (see data). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the estimated rates of major birth defects (2.2%-2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine. clinical considerations disease-
zolmitriptan - zolmitriptan tablet, film coated zolmitriptan - zolmitriptan tablet, orally disintegrating
macleods pharmaceuticals limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 2.5 mg - zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan are administered to treat any subsequent attacks. - zolmitriptan is not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see warnings and precautions (
zolmitriptano generis phar 2.5 mg comprimido orodispersível
generis phar, unipessoal lda. - zolmitriptano - comprimido orodispersível - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano generis phar 2.5 mg comprimido orodispersível
generis phar, unipessoal lda. - zolmitriptano - comprimido orodispersível - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano generis phar 2.5 mg comprimido revestido por película
generis phar, unipessoal lda. - zolmitriptano - comprimido revestido por película - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano generis phar 5 mg comprimido revestido por película
generis phar, unipessoal lda. - zolmitriptano - comprimido revestido por película - 5 mg - zolmitriptano 5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano vitória 5 mg comprimido orodispersível
laboratórios vitória, s.a. - zolmitriptano - comprimido orodispersível - 5 mg - zolmitriptano 5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano vitória 2.5 mg comprimido orodispersível
laboratórios vitória, s.a. - zolmitriptano - comprimido orodispersível - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano generis phar 2.5 mg comprimido orodispersível
generis phar, unipessoal lda. - zolmitriptano - comprimido orodispersível - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração
zolmitriptano generis phar 2.5 mg comprimido revestido por película
generis phar, unipessoal lda. - zolmitriptano - comprimido revestido por película - 2.5 mg - zolmitriptano 2.5 mg - zolmitriptan - genérico - duração do tratamento: curta ou média duração